Cloning of the feline cytokines 11-2, IFNγ and GM-CSF for an adjuvant nonviral gene therapy of feline fibrosarcoma;Klonieren der Felinen Zytokin-Gene IL-2, IFNγ und GM-CSF zum Adjuvanten, Nonviralen Gentherapeutischen Einsatz beim Fibrosarkom der Katze

Kleintierpraxis

Volumn 52, Issue 9, 2007, Pages 569-578

  Schwarz, Bianca ^a,b,d   Kempf, Tina ^a,b   Schillinger, Ulrike ^a   Brilu, Thomas ^a   Plank, Christian ^a   Köstlin, Roberto ^c   Gänsbacher, Bernd ^a   Hirschberger, Johannes ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Medizinische Kleintierklinik ^*  (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Cytokine gene therapy; Feline fibrosarcoma; Granulocyte macrophage colony stimulating factor; Interferon v; Interleukin 2

Indexed keywords

FELIDAE; MAMMALIA;

EID: 36749054646     PISSN: 00232076     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ARAI M, DARMAN J, LEWIS A, YAMAMOTO JK, DARMEN J (2000): The use of human hematopoietic growth factors (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected cats. Vet Immunol Immunopathol 77: 71-92.
2. ARGYLE DJ, SMITH K, MCBRIDE K, FULTON R, ONION DE (1995): Nucleotide and predicted peptide sequence of feline interferon-gamma (IFNy). DNA Seq 5: 169-171.
3. ARGYLE DJ, HARRIS M, LAWRENCE C, MCBRIDE K, BARRON R, MCGILLIVRAY C, ONIONS DE (1998): Expression of feline recombinant interferon-gamma in baculovirus and demonstration of biological activity. Vet Immunol Immunopathol 64: 97-105.
4. ARMITAGE JO (1998): Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood 92: 4491-4508.
5. BLAKESLEE J, NOLL G, OLSEN R, TRIOZZI PL (1998): Adoptive immunotherapy of feline leukemia virus infection using autologous lymphnode lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 18:1-6.
6. BULL ME, VAHLENKAMP TW, DOW JL, COLLISON EW, WINSLOW BJ, PHADKE AP (2004): Spontaneous T cell apoptosis in feline immunodeficiency virus (FIV)-infected cats is inhibited by IL2 and anti-B7.1 antibodies. Vet Immunol Immunopathol 99: 25-37.
7. COUTO SS, GRIFFEY SM, DUARTE PC, MADEWELL BR (2002): Feline vaccine-associated fibrosarcoma: morphologic distinctions. Vet Pathol 39: 33-41.
8. COZZIPJ, PADRID PA, TAKEDAJ, ALEGRE ML, YUHKIN, LEFF AR (1993): Sequence and functional characterization of feline interleukin 2. Biochem Biophys Res Commun 194: 1038-1043.
9. COZZI PJ, PADRID P, TOMPKINS MB, ALEGRE ML, TAKEDA J, LEFF AR (1995): Bioactivity of recombinant feline inter leukin-2 on human and feline leukocytes. Vet Immunol Immunopathol 48: 27-33.
10. DAVIS LS, LIPSKY PE, BOTTOMLY K (2000): Measurement of human and murine interleukin 2 and interleukin 4. In: Current protocols on Immunology, John Wiley and Son, Inc. 6.3.1-6.3.13.
11. DUNHAM SP, ONIONS PE (2001): Isolation, nucleotide sequence and expression of a cDNA encoding feline granulocyte colony-stimulating factor. Cytokine 14: 347-351.
12. DUNHAM SP, BRUCE J (2004): Isolation, expression and bioactivity of feline granulocyte-macrophage colony-stimulating factor. Gene 332: 97-106.
13. FINSINGER D, REMY JS, ERBACHER P, KOCH C, PLANK C (2000): Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery. Gene Ther 7:1183-1192.
14. GENBANK DES NCBI (2004): www2.ncbi.nkm.nih.gov/cgi.bin/genbank.
15. JOURDIER TM, MOSTE C, BONNET MC, DELISLE F, TAFANI JP, DEVAUCHELLE P, TARTAGLIA J, MOINGEON P (2003): Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2). Gene Ther 10: 2126-2132.
16. KEMPF T (2005): Nonviraler Gentiansfer der felinen ZytokinGene IL-2, IFN-y und GM-CSF als adjuvante Immuntherapie beim Fibrosarkom der Katze - Eine klinische Phase-I Studie. München, LMU, veterinärmed. Fak., Diss.
17. KJAERGAARD N, WIEDMANN K, BRILL T, KÖSTLIN R, LUDWIG J, WIELAND S, HENKE J, SCHILLINGER U, GÄNSBACHER U, HIRSCHBERGER J (2002): Phase I-Studie zur adjuvanten Therapie des felinen Fibroarkoms mit GM-CSF. 11. DVG-Jahrestagung der Fachgruppe "Innere Medizin und Labordiagnostik", München 2002, in Tierärztl Prax 30 (K) 1: 94.
18. LUDWIG J, WIELAND S, HOMANN H, KÖSTLIN R, BRILL T, WIEDMANN K, KJAERGAARD N, HENKE J, SCHILLINGER U, ERHARDT W, GÄNSBACHER B, HIRSCHBERGER J (2002): Phase II-Studie zur adjuvanten Therapie des felinen Fibrosarkoms mit Ad-IL-2 und Ad-IFN7- 11. DVG-Jahrestagung der Fachgruppe "Innere Medizin und Labordiagnostik", München 2002 in Tierärztl Prax 30 (K) 1: 94.
19. MÜLLER-HEIDELBERG M (2003): Immunologisches Monitoring der Gentherapie des Fibrosarkoms der Katze - Zytokinkinetik und humorale Antwort auf Vektor und Transgen. München, LMU, veterinärmed. Fak., Diss.
20. QUINTIN-COLONNA F, DEVAUCHELLE P, FRADELIZI D, MOUROT B, FAURE T, KOURILSKY P, ROTH C, MEHTALI M (1996): Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intra-rumoral administration of histoincompatible cells expressing human interleukin-2. Gene Ther 3:1104-1112.
21. SCHERER F, SCHILLINGER U, PUTZ U, STEMBERGER A, PLANK C (2002): Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo. J Gene Med 4: 634-643.
22. SCHIJNS VE, WIERDA CM, VAHLENKAMP TW, HORZINEK MC, DE GROOT RJ (1995): Molecular cloning and expression of cat interferon-gamma. Immunogenetics 42: 440-441.
23. SCHIJNS VE, SCHOLTES NC, ZUILEKOM HI, SANDERS LE, NICOLSON L, ARGYLE DJ (2002): Facilitation of antibody forming response to viral vaccine antigens in young cats by recombinant baculovirus-expressed feline IFN-gamma. Vaccine 20: 1718-1724.
24. SCHILLINGER U (2002): Verschiedene Applikationsformen nicht-viraler Genvektoren im Tiermodell unter besonderer Berücksichtigung des lokalen Gentransfers. München, LMU, veterinärmed. Fak., Diss.
25. SCHILLINGER U, KJAERGAARD N, WIEDMANN K, LÖCHER A, SCHLEMMER S, SCHWARZ B, KEMPF T, HIRSCHBERGER J, KÖSTLIN R, PLANK C, GÄNSBACHER B, BRILL T (2004): Immuno gene therapy of feline fibrosarcoma using intratumoral Magnetofection for gene delivery - Preliminary results of a veterinary clinical study. ASGT-Kongress, Minneapolis, USA 2004.
26. TOMPKINS MB, OGILVIE GK, FRANKLIN RA, KELLEY RW, TOMPKINS WA (1987): Induction of IL-2 and lymphokine activated killer cells in the cat. Vet Immunol Immunopathol 16: 1-10.
27. WHITESIDE TL (2002): Cytokine assays. Biotechniques 33: 4-15.
28. WIEDMANN K (2005): Klinische Phase I-Studie zur neoadjuvanten immunstimulierenden Therapie des felinen Fibrosarkoms mit Interleukin-2 und Interferon-γ. München, LMU, veterinärmed. Fak., Diss.
29. WIELAND S (2002): Klinische Phase I-Studie zur gentherapeutischen Immunstimulation durch Interleukin-2 und Interferon y als adjuvanter Behandlung des felinen Fibrosarkoms. München, LMU, veterinärmed. Fak., Diss.
30. YAMAMOTO A, IWATA A, TUCHIYA K, KATSUMA A, OISHI K, SAITO T, TSUJIMOTO H, HASAGAWA A, UEDA S (2001): Molecular cloning and expression of the cDNA encoding feline granulocyte colony-stimulating factor. Gene 274: 263-269.